Vicadrostat

N/A

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameVicadrostat
Drug Alias NameBI-690517
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldosterone synthase inhibitorsCytochrome P450 11B2 inhibitors
TargetsCytochrome P450 11B2
Therapy Area/IndicationsDiabetes Mellitus, Type 2HypertensionHeart Failure +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[55] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. KgUniversity Medical Center GroningenBoehringer Ingelheim Pharma Gmbh & Co Kg +[5] 
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2HypertensionHeart Failure +[7] 
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A